indigent clinic in Hickory, North Carolina. I also continue to teach at Wake Forest University School of Medicine.
I'm pleased to testify before you today on behalf of the Endocrine Society, where I serve on the Clinical Affairs Committee. The Endocrine Society, founded in 1916, consists of over 11,000 physicians and scientists dedicated to research and patient care in the field of endocrinology. Our clinician members are involved in the daily treatment of patients with hormone disorders, including thyroid disease. We publish four peer-reviewed journals, Endocrinology, Endocrine Reviews, the Journal of Clinical Endocrinology and Metabolism, and Molecular Endocrinology.
I have no current affiliation, financial or other, with any manufacturer of levothyroxine products. The Endocrine Society receives financial support in the form of unrestricted educational grants from several manufacturers of thyroid drugs, including Abbott, King, and Watson.
It is our dedication to the treatment of patients with thyroid disorders that brings us to this